Delivery Order SPE2DR25D2209-SPE2DR26FD6TP
- Not listed
- The Defense Logistics Agency awarded a $2,311.22 delivery order to AmerisourceBergen Drug Corp for naloxone 0.4 mg/ml vials, with an ultimate completion date of December 23, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,554.28. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Naloxone 0.4 mg/mL vials valued at $4,056.58 with an ultimate completion date of December 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $2,093.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone 0.4 mg/mL in vial format. The contract, which represents no set-aside designation, is scheduled for completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,769.61. This firm fixed-price delivery order, with an ultimate completion date of January 6, 2026, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded to the vendor, demonstrating its capability to meet...
- The Defense Logistics Agency awarded a $1,256.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials on September 23, 2025, with completion scheduled for September 24, 2025. The delivery order was issued without set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and represents a major pharmaceutical distributor specializing in federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.67 to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/mL vials. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location and deliver the pharmaceutical product to...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.43 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on December 18, 2025, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,554.14 to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/mL vials. This firm fixed-price delivery order, awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside provisions and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6TPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone 0.4 mg/mL vials, valued at $1,385.79, with an ultimate completion date of January 15, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded on January 14, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, including military and veteran medical programs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. The naloxone delivery fulfills critical medical supply needs for federal healthcare systems through the DLA's established pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/13/26 |